⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 24 in last 7 days 🍎 Food: 211 in last 7 days 🧸 Products: 73 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 24 in last 7 days 🍎 Food: 211 in last 7 days 🧸 Products: 73 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago
🛡️ EUSW
🇬🇧
💊 Medicine AT May 16, 2022

Metronidazol Vioser 500 mg/100 ml Infusionslösung 500/100 mg/ml (Infusionslösung)

📷 Wikipedia: Metronidazole · Source
Metronidazol Vioser 500 mg/100 ml Infusionslösung 500/100 mg/ml (Infusionslösung)
📷 Wikipedia: Metronidazole · Source
Metronidazole Vioser 500 mg/100 ml infusion solution 500/100 mg/ml (infusion solution) is delayed in delivery. Affected packs: 1 vial [limited availability since 10 May 2022].
🗄
Archived (older alert)
This alert was reported 1475 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
12 days in total
May 18, 2026 May 30, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? Metronidazole is an antibiotic medicine given by drip into a vein. It treats some infections.

What's happening? There is a delay in getting new packs of this medicine. Only a few packs are available now.

Does this affect me? If you take this medicine in Austria, your supply may be limited.

What should I do? Ask your pharmacist or doctor about other options while waiting for more supplies.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Agency-published detail

ATC: J01XD01 · Reason: Verzögerung bei der Auslieferung · Marketing authorisation holder: Vioser S.A. Parenteral Solutions Industry, 9th Km National Road Trikala Larisa Taxiarches -, 421 00 Trikala, Hellenic Republic · Affected packs: 1 Stück Durchstechflasche [eingeschränkt verfügbar, since 2022-05-10]

First published
May 16, 2022
Last refreshed by us
1 week ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

What is this medicine shortage alert about?
Metronidazol Vioser 500 mg/100 ml Infusionslösung 500/100 mg/ml (Infusionslösung). Metronidazole Vioser 500 mg/100 ml infusion solution 500/100 mg/ml (infusion solution) is delayed in delivery. Affected packs: 1 vial [limited availability since 10 May 2022].
When was this alert issued?
This alert was issued on May 16, 2022 by BASG (Austria).
Which countries are affected?
The alert applies to Austria.
How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.